Cytori to Webcast Second Quarter Financial Results August 9 and Annual Shareholder Meeting on August 16
(firmenpresse) - SAN DIEGO, CA -- (Marketwire) -- 08/02/11 -- Cytori Therapeutics (NASDAQ: CYTX) will host a webcast to discuss its second quarter financial results and provide a commercial and development pipeline update on Tuesday, August 9, 2011 at 5:00 PM Eastern Time.
Prior to the webcast at approximately 4:05 PM Eastern Time on August 9, Cytori will issue its second quarter results earnings release and post its quarterly shareholder letter to its Investor Relations homepage.
In addition, Cytori will be hosting a webcast of its Annual Shareholder Meeting on Tuesday, August 16 at 12 PM Eastern Time. Both webcasts will be available both live and by replay two hours after the conclusion of the event on the Company's website, under "Webcasts" on the Investor Relations page ().
Cytori is a world leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the United States. Our StemSource® product line is sold globally for cell banking and research applications. Our PureGraft™ products are available in North America and Europe for fat grafting procedures.
Megan McCormick
858.875.5279
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.08.2011 - 06:00 Uhr
Sprache: Deutsch
News-ID 1026493
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SAN DIEGO, CA
Phone:
Kategorie:
Healthcare
Anmerkungen:
Diese Pressemitteilung wurde bisher 223 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cytori to Webcast Second Quarter Financial Results August 9 and Annual Shareholder Meeting on August 16
"
steht unter der journalistisch-redaktionellen Verantwortung von
Cytori Therapeutics, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
